China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Two novel TRPC6 variants in familial focal segmental glomerulosclerosis prolong receptor-evoked calcium signalling'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132903
Registration Time: 2026/09/20
Type: Observational study
Primary Sponsor: Zhejiang Provincial People's Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341062
Published by HT Digital Content Services with permission from Health Daily Digest....